Tirzepatide Significantly Reduces Sleep Disruptions
The dual GIP/GLP-1 agonist is the first drug to show benefit in patients with obstructive sleep apnea.
Medscape Medical News
source https://www.medscape.com/viewarticle/tirzepatide-significantly-reduces-sleep-disruptions-2024a1000bm1?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/tirzepatide-significantly-reduces-sleep-disruptions-2024a1000bm1?src=rss
Comments
Post a Comment